Post-approval studies (Phase 4)UnknownNCT03890497
What this trial is testing
Assessment of Poliovirus Type 2 Immunogenicity of One and Two Dose Schedule With IPV and fIPV When Administered at 9-13 Months of Age in Bangladesh
Who this might be right for
Poliomyelitis
International Centre for Diarrhoeal Disease Research, Bangladesh 300